Report Detail
Global (United States, European Union and China) Biogeneric Drugs Market Research Report 2019-2025
- RnM3579830 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars in Europe, follows-on-biologics in US and subsequent entry biological in japan. Due to their high degree of similarity with the biological reference product, they have no clinically evidenced and meaningful differences from the reference product in terms of quality, safety or efficacy. Biogenerics drugs provide effective treatment for number of serious and life-threatening illness because of their high specificity and activity. Biogeneric are more complex compared to small molecule drugs. Their quality and safety are highly dependent on the process of production (choice of cell type, development of the genetically modified cell for production, etc.), purification and formulation. The constitution of the biogeneric drugs can be either small molecules such as human insulin or erythropoietin, or complex molecules such as monoclonal antibodies. Biogeneric drugs are increasing gaining prominence given the loss of exclusivity of big branded drugs. In Europe, biogenerics can be marketed through independent applicant following expiry of patent and market exclusivity periods of the reference product. Regulatory harmonization, naming and labelling, innovative licensure norms and route to market for the biogeneric drugs are issues expected to gain attention and traction from big drug makers in the forthcoming years.
Biogeneric drugs market is expected to increase in forecast period due to increased treatment options, value added services to care patient and healthcare community. Due to drugs introduces competition, increasing affordability of biologics which delivers saving for healthcare systems are the same factors which increase biogeneric drugs market. Introduction of affordable, high-quality biogenerics drugs improves access to life changing medicine for patients worldwide. Opportunities for generic drug products is huge but there are regulations that must be adhered to when strategizing the best ways to maximize a company’s return. Government regulation may be adhere the growth of drug development investment or planning an entry into a market with a new biogeneric products.
In 2019, the market size of Biogeneric Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biogeneric Drugs.
This report studies the global market size of Biogeneric Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biogeneric Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sandoz International
Teva pharmaceutical industries
Mylan
3SBio
Shanghai Fosun Pharmaceutical
Tonghua Dongbao Pharmaceutical
Biocon
Reliance life sciences
Probiomed
Biosidus
AMEGA Biotech
Celltrion
LG life Science
Dong-A Pharmaceutical
Market Segment by Product Type
Insulins
Growth Hormones
Monoclonal Antibodies
Others
Market Segment by Application
Hospital
Clinics
Research Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Biogeneric Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biogeneric Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Biogeneric Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Biogeneric Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Insulins
- 1.3.3 Growth Hormones
- 1.3.4 Monoclonal Antibodies
- 1.3.5 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Biogeneric Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Clinics
- 1.4.4 Research Centers
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Biogeneric Drugs Market Size
- 2.1.1 Global Biogeneric Drugs Revenue 2014-2025
- 2.1.2 Global Biogeneric Drugs Sales 2014-2025
- 2.2 Biogeneric Drugs Growth Rate by Regions
- 2.2.1 Global Biogeneric Drugs Sales by Regions 2014-2019
- 2.2.2 Global Biogeneric Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Biogeneric Drugs Sales by Manufacturers
- 3.1.1 Biogeneric Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Biogeneric Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Biogeneric Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Biogeneric Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Biogeneric Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Biogeneric Drugs Price by Manufacturers
- 3.4 Key Manufacturers Biogeneric Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Biogeneric Drugs Market
- 3.6 Key Manufacturers Biogeneric Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Insulins Sales and Revenue (2014-2019)
- 4.1.2 Growth Hormones Sales and Revenue (2014-2019)
- 4.1.3 Monoclonal Antibodies Sales and Revenue (2014-2019)
- 4.1.4 Others Sales and Revenue (2014-2019)
- 4.2 Global Biogeneric Drugs Sales Market Share by Type
- 4.3 Global Biogeneric Drugs Revenue Market Share by Type
- 4.4 Biogeneric Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Biogeneric Drugs Sales by Application
6 United States
- 6.1 United States Biogeneric Drugs Breakdown Data by Company
- 6.2 United States Biogeneric Drugs Breakdown Data by Type
- 6.3 United States Biogeneric Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Biogeneric Drugs Breakdown Data by Company
- 7.2 European Union Biogeneric Drugs Breakdown Data by Type
- 7.3 European Union Biogeneric Drugs Breakdown Data by Application
8 China
- 8.1 China Biogeneric Drugs Breakdown Data by Company
- 8.2 China Biogeneric Drugs Breakdown Data by Type
- 8.3 China Biogeneric Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Biogeneric Drugs Breakdown Data by Company
- 9.2 Rest of World Biogeneric Drugs Breakdown Data by Type
- 9.3 Rest of World Biogeneric Drugs Breakdown Data by Application
- 9.4 Rest of World Biogeneric Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Biogeneric Drugs Sales by Countries
- 9.4.2 Rest of World Biogeneric Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Sandoz International
- 10.1.1 Sandoz International Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.1.4 Biogeneric Drugs Product Introduction
- 10.1.5 Sandoz International Recent Development
- 10.2 Teva pharmaceutical industries
- 10.2.1 Teva pharmaceutical industries Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.2.4 Biogeneric Drugs Product Introduction
- 10.2.5 Teva pharmaceutical industries Recent Development
- 10.3 Mylan
- 10.3.1 Mylan Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.3.4 Biogeneric Drugs Product Introduction
- 10.3.5 Mylan Recent Development
- 10.4 3SBio
- 10.4.1 3SBio Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.4.4 Biogeneric Drugs Product Introduction
- 10.4.5 3SBio Recent Development
- 10.5 Shanghai Fosun Pharmaceutical
- 10.5.1 Shanghai Fosun Pharmaceutical Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.5.4 Biogeneric Drugs Product Introduction
- 10.5.5 Shanghai Fosun Pharmaceutical Recent Development
- 10.6 Tonghua Dongbao Pharmaceutical
- 10.6.1 Tonghua Dongbao Pharmaceutical Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.6.4 Biogeneric Drugs Product Introduction
- 10.6.5 Tonghua Dongbao Pharmaceutical Recent Development
- 10.7 Biocon
- 10.7.1 Biocon Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.7.4 Biogeneric Drugs Product Introduction
- 10.7.5 Biocon Recent Development
- 10.8 Reliance life sciences
- 10.8.1 Reliance life sciences Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.8.4 Biogeneric Drugs Product Introduction
- 10.8.5 Reliance life sciences Recent Development
- 10.9 Probiomed
- 10.9.1 Probiomed Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.9.4 Biogeneric Drugs Product Introduction
- 10.9.5 Probiomed Recent Development
- 10.10 Biosidus
- 10.10.1 Biosidus Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Biogeneric Drugs
- 10.10.4 Biogeneric Drugs Product Introduction
- 10.10.5 Biosidus Recent Development
- 10.11 AMEGA Biotech
- 10.12 Celltrion
- 10.13 LG life Science
- 10.14 Dong-A Pharmaceutical
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Biogeneric Drugs Sales Channels
- 11.2.2 Biogeneric Drugs Distributors
- 11.3 Biogeneric Drugs Customers
12 Market Forecast
- 12.1 Global Biogeneric Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Biogeneric Drugs Sales Forecast by Type
- 12.3 Global Biogeneric Drugs Sales Forecast by Application
- 12.4 Biogeneric Drugs Forecast by Regions
- 12.4.1 Global Biogeneric Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Biogeneric Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Biogeneric Drugs. Industry analysis & Market Report on Biogeneric Drugs is a syndicated market report, published as Global (United States, European Union and China) Biogeneric Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Biogeneric Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
